ICRA revises domestic pharma industry outlook to negative due to coronavirus outbreak Medical Dialogues Bureau21 Feb 2020 6:52 AM GMTAccording to Icra research, domestic API manufacturers have an inventory of one-two months, which should adequately support their production till...
Fortis put 'on watch under implications' by ICRA Geeta Sharma Sharma24 Jun 2016 3:22 PM GMTMumbai: Fortis Healthcare's A+ instruments- a 250 crore NCD programme and another 200 crore fund base limits have been put 'on watch under...